Interconnections between apoptotic, autophagic and necrotic pathways: Implications for cancer therapy development

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 1, 2013, Pages 12-29

  Jain, Mayur V ^a   Paczulla, Anna M ^b   Klonisch, Thomas ^c   Dimgba, Florence N ^a   Rao, Sahana B ^a   Roberg, Karin ^d   Schweizer, Frank ^c   Lengerke, Claudia ^b   Davoodpour, Padideh ^a   Palicharla, Vivek R ^e   Maddika, Subbareddy ^e   Los, Marek ^a,f  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF MANITOBA   (Canada)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

^f BioApplications Enterprises Winnipeg   (Canada)

Author keywords

Bcl2 family; Cancer therapy; Erk; FOXO; P53; PI3 K; Rheb; S6K

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; DEATH RECEPTOR; PROTEIN BCL 2;

APOPTOSIS; AUTOPHAGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; NECROSIS; NEOPLASM; PATHOLOGY; PHYSIOLOGICAL STRESS; REVIEW; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CASPASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; NECROSIS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84873109651     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12001     Document Type: Review

References (244)

1. Cherlonneix L. L'équivocité vive. Une nouvelle représentation du vivant [The vivid equivocity. A new representation of living]. Paris: Paru le; 2008.
2. Maddika S, Ande SR, Panigrahi S, et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Update. 2007; 10: 13-29.
3. Desbarats L, Schneider A, Muller D, et al. Myc: a single gene controls both proliferation and apoptosis in mammalian cells. Experientia. 1996; 52: 1123-9.
4. Dong J, Naito M, Tsuruo T. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells. Oncogene. 1997; 15: 639-47.
5. Stroh C, Cassens U, Samraj AK, et al. The role of caspases in cryoinjury: caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells. FASEB J. 2002; 16: 1651-3.
6. Chaabane W, User SD, El-Gazzah M, et al. Autophagy, apoptosis, mitoptosis and necrosis - interdependence between those pathways and effects on cancer. Arch Immunol Ther Exp. 2013; 61. doi: 10.1007/s00005-012-0205-y.
7. Vandenabeele P, Vanden Berghe T, Festjens N. Caspase inhibitors promote alternative cell death pathways. Sci STKE. 2006; 2006: pe44.
8. Alavian SM, Ande SR, Coombs KM, et al. Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development. J Viral Hepat. 2011; 18: 821-30.
9. Ghavami S, Kerkhoff C, Chazin WJ, et al. S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim Biophys Acta. 2008; 1783: 297-311.
10. Panigrahi S, Stetefeld J, Jangamreddy JR, et al. Modeling of molecular interaction between apoptin, BCR-Abl and CrkL - an alternative approach to conventional rational drug design. PLoS ONE. 2012; 7: e28395.
11. Rashedi I, Panigrahi S, Ezzati P, et al. Autoimmunity and apoptosis - therapeutic implications. Curr Med Chem. 2007; 14: 3139-59.
12. Ghavami S, Hashemi M, Ande SR, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009; 46: 497-510.
13. Los M, van de Craen M, Penning CL, et al. Requirement of an ICE/Ced-3 protease for Fas/Apo-1-1mediated apoptosis. Nature. 1995; 371: 81-3.
14. Kreuter M, Langer C, Kerkhoff C, et al. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development. Arch Immunol Ther Exp. 2004; 52: 141-55.
15. Los M, Gibson S. Apoptotic pathways as target for novel therapies of cancer and other diseases. New York: Springer; 2005.
16. Los M, Burek CJ, Stroh C, et al. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov Today. 2003; 8: 67-77.
17. Vincent FC, Los MJ. New potential instrument to fight hepatocellular cancer by restoring p53. Hepat Mon. 2011; 11: 331-2.
18. Elrod HA, Fan S, Muller S, et al. Analysis of death receptor 5 and caspase-8 expression in primary and metastatic head and neck squamous cell carcinoma and their prognostic impact. PLoS ONE. 2010; 5: e12178.
19. Finlay D, Richardson RD, Landberg LK, et al. Novel HTS strategy identifies TRAIL-sensitizing compounds acting specifically through the caspase-8 apoptotic axis. PLoS ONE. 2010; 5: e13375.
20. Holoch PA, Griffith TS. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur J Pharmacol. 2009; 625: 63-72.
21. Noteborn MH. Proteins selectively killing tumor cells. Eur J Pharmacol. 2009; 625: 165-73.
22. Pennica D, Nedwin GE, Hayflick JS, et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984; 312: 724-9.
23. Shirai T, Yamaguchi H, Ito H, et al. Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature. 1985; 313: 803-6.
24. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature. 1997; 385: 729-33.
25. Skoog T, van't Hooft FM, Kallin B, et al. A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999; 8: 1443-9.
26. Mahmood Z, Shukla Y. Death receptors: targets for cancer therapy. Exp Cell Res. 2010; 316: 887-99.
27. Los M, Walczak H. Caspases - their role in cell death and cell survival. New York: Kluwer Academic Press; 2002.
28. Zhivotovsky B. Caspases: the enzymes of death. Essays Biochem. 2003; 39: 25-40.
29. Fadeel B, Orrenius S, Zhivotovsky B. The most unkindest cut of all: on the multiple roles of mammalian caspases. Leukemia. 2000; 14: 1514-25.
30. Ghazanfari T, Sharifnia Z, Yaraee R, et al. Serum soluble Fas ligand and nitric oxide in long-term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol. 2009; 9: 1489-93.
31. Los M, Stroh C, Janicke RU, et al. Caspases: more than just killers? Trends Immunol. 2001; 22: 31-4.
32. Cecconi F, Alvarez-Bolado G, Meyer BI, et al. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 1998; 94: 727-37.
33. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 1996; 85: 817-27.
34. Feoktistova M, Geserick P, Kellert B, et al. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell. 2011; 43: 449-63.
35. Bertrand MJ, Vandenabeele P. The Ripoptosome: death decision in the cytosol. Mol Cell. 2011; 43: 323-5.
36. Los M, Wesselborg S, Schulze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity. 1999; 10: 629-39.
37. Slee EA, Harte MT, Kluck RM, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol. 1999; 144: 281-92.
38. Niizuma K, Yoshioka H, Chen H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim Biophys Acta. 2010; 1802: 92-9.
39. Sadowski-Debbing K, Coy JF, Mier W, et al. Caspases - their role in apoptosis and other physiological processes as revealed by knock-out studies. Arch Immunol Ther Exp. 2002; 50: 19-34.
40. Stennicke HR, Salvesen GS. Caspases - controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta. 2000; 1477: 299-306.
41. Panigrahi S, Klonisch T, Los M. The art of killing: double stroke with apoptin and survivin as a novel approach in cancer therapy. Cancer Biol Ther. 2008; 7: 1061-2.
42. Philchenkov A, Zavelevich M, Kroczak TJ, et al. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol. 2004; 26: 82-97.
43. Ghavami S, Mutawe MM, Hauff K, et al. Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c. Biochim Biophys Acta. 2010; 1803: 452-67.
44. Tsujimoto Y, Gorham J, Cossman J, et al. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science. 1985; 229: 1390-3.
45. Lithgow T, van Driel R, Bertram JF, et al. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ. 1994; 5: 411-7.
46. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008; 9: 47-59.
47. Willis SN, Chen L, Dewson G, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005; 19: 1294-305.
48. Li H, Zhu H, Xu CJ, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998; 94: 491-501.
49. Puthalakath H, Huang DC, O'Reilly LA, et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell. 1999; 3: 287-96.
50. Rodriguez D, Rojas-Rivera D, Hetz C. Integrating stress signals at the endoplasmic reticulum: the BCL-2 protein family rheostat. Biochim Biophys Acta. 2011; 1813: 564-74.
51. Weston RT, Puthalakath H. Endoplasmic reticulum stress and BCL-2 family members. Adv Exp Med Biol. 2010; 687: 65-77.
52. Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005; 123: 321-34.
53. Lauber K, Blumenthal SG, Waibel M, et al. Clearance of apoptotic cells: getting rid of the corpses. Mol Cell. 2004; 14: 277-87.
54. Mueller RB, Sheriff A, Gaipl US, et al. Attraction of phagocytes by apoptotic cells is mediated by lysophosphatidylcholine. Autoimmunity. 2007; 40: 342-4.
55. Gardai SJ, Bratton DL, Ogden CA, et al. Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol. 2006; 79: 896-903.
56. Tada K, Tanaka M, Hanayama R, et al. Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1. J Immunol. 2003; 171: 5718-26.
57. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008; 132: 27-42.
58. Essick EE, Sam F. Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid Med Cell Longev. 2010; 3: 168-77.
59. Codogno P, Mehrpour M, Proikas-Cezanne T. Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol. 2011; 13: 7-12.
60. Eskelinen EL, Saftig P. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim Biophys Acta. 2009; 1793: 664-73.
61. Mehrpour M, Esclatine A, Beau I, et al. Overview of macroautophagy regulation in mammalian cells. Cell Res. 2010; 20: 748-62.
62. Huang J, Klionsky DJ. Autophagy and human disease. Cell Cycle. 2007; 6: 1837-49.
63. Klionsky DJ, Cregg JM, Dunn WA Jr, et al. A unified nomenclature for yeast autophagy-related genes. Dev Cell. 2003; 5: 539-45.
64. Nakatogawa H, Suzuki K, Kamada Y, et al. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol. 2009; 10: 458-67.
65. Hutchins MU, Veenhuis M, Klionsky DJ. Peroxisome degradation in Saccharomyces cerevisiae is dependent on machinery of macroautophagy and the Cvt pathway. J Cell Sci. 1999; 112: 4079-87.
66. Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009; 20: 1992-2003.
67. Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011; 13: 132-41.
68. Kirisako T, Baba M, Ishihara N, et al. Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J Cell Biol. 1999; 147: 435-46.
69. Kabeya Y, Mizushima N, Yamamoto A, et al. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci. 2004; 117: 2805-12.
70. Ichimura Y, Kirisako T, Takao T, et al. A ubiquitin-like system mediates protein lipidation. Nature. 2000; 408: 488-92.
71. Ichimura Y, Imamura Y, Emoto K, et al. In vivo and in vitro reconstitution of Atg8 conjugation essential for autophagy. J Biol Chem. 2004; 279: 40584-92.
72. Yoshimori T. Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun. 2004; 313: 453-8.
73. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000; 19: 5720-8.
74. Duprez L, Wirawan E, Vanden Berghe T, et al. Major cell death pathways at a glance. Microbes Infect. 2009; 11: 1050-62.
75. Yang YP, Liang ZQ, Gu ZL, et al. Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin. 2005; 26: 1421-34.
76. Weichhart T. Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life. Methods Mol Biol. 2012; 821: 1-14.
77. Pyo JO, Nah J, Jung YK. Molecules and their functions in autophagy. Exp Mol Med. 2012; 44: 73-80.
78. Cloughesy TF, Yoshimoto K, Nghiemphu P, et al. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med. 2008; 5: e8.
79. Mita MM, Mita AC, Chu QS, et al. Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies. J Clin Oncol. 2008; 26: 361-7.
80. Long X, Ortiz-Vega S, Lin Y, et al. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J Biol Chem. 2005; 280: 23433-6.
81. Sancak Y, Thoreen CC, Peterson TR, et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell. 2007; 25: 903-15.
82. Garami A, Zwartkruis FJ, Nobukuni T, et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell. 2003; 11: 1457-66.
83. Inoki K, Li Y, Xu T, et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003; 17: 1829-34.
84. Huang J, Dibble CC, Matsuzaki M, et al. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol. 2008; 28: 4104-15.
85. Ma L, Chen Z, Erdjument-Bromage H, et al. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 2005; 121: 179-93.
86. Li L, Ross AH. Why is PTEN an important tumor suppressor? J Cell Biochem. 2007; 102: 1368-74.
87. Maddika S, Kavela S, Rani N, et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nat Cell Biol. 2012; 13: 728-33.
88. Los M, Maddika S, Erb B, et al. Switching Akt: from survival signaling to deadly response. BioEssays. 2009; 31: 492-5.
89. Wurmser AE, Emr SD. Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 PtdIns 3-kinase in autophagy. J Cell Biol. 2002; 158: 761-72.
90. Moretti L, Attia A, Kim KW, et al. Crosstalk between Bak/Bax and mTOR signaling regulates radiation-induced autophagy. Autophagy. 2007; 3: 142-4.
91. Hoyer-Hansen M, Jaattela M. Autophagy: an emerging target for cancer therapy. Autophagy. 2008; 4: 574-80.
92. Boya P, Gonzalez-Polo RA, Casares N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005; 25: 1025-40.
93. Lum JJ, Bauer DE, Kong M, et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005; 120: 237-48.
94. Wang Y, Singh R, Massey AC, et al. Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J Biol Chem. 2008; 283: 4766-77.
95. Fung C, Lock R, Gao S, et al. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell. 2008; 19: 797-806.
96. Avivar-Valderas A, Salas E, Bobrovnikova-Marjon E, et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol. 2011; 31: 3616-29.
97. Yin L, Kharbanda S, Kufe D. MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation. Int J Oncol. 2009; 34: 1691-9.
98. Colell A, Ricci JE, Tait S, et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell. 2007; 129: 983-97.
99. Los M, Mozoluk M, Ferrari D, et al. Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell. 2002; 13: 978-88.
100. Huang Q, Shen HM. To die or to live: the dual role of poly(ADP-ribose) polymerase-1 in autophagy and necrosis under oxidative stress and DNA damage. Autophagy. 2009; 5: 273-6.
101. Hoyer-Hansen M, Jaattela M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007; 14: 1576-82.
102. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007; 17: 422-7.
103. Gozuacik D, Kimchi A. Autophagy and cell death. Curr Top Dev Biol. 2007; 78: 217-45.
104. Maiuri MC, Zalckvar E, Kimchi A, et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007; 8: 741-52.
105. Nivon M, Richet E, Codogno P, et al. Autophagy activation by NFkappaB is essential for cell survival after heat shock. Autophagy. 2009; 5: 766-83.
106. Banhegyi G, Baumeister P, Benedetti A, et al. Endoplasmic reticulum stress. Ann N Y Acad Sci. 2007; 1113: 58-71.
107. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005; 74: 739-89.
108. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 2007; 26: 1324-37.
109. Kouroku Y, Fujita E, Tanida I, et al. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 2007; 14: 230-9.
110. Ogata M, Hino S, Saito A, et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol. 2006; 26: 9220-31.
111. Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol. 2006; 4: e423.
112. Qu X, Zou Z, Sun Q, et al. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell. 2007; 128: 931-46.
113. Bovellan M, Fritzsche M, Stevens C, et al. Death-associated protein kinase (DAPK) and signal transduction: blebbing in programmed cell death. FEBS J. 2010; 277: 58-65.
114. Jia L, Dourmashkin RR, Allen PD, et al. Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol. 1997; 98: 673-85.
115. Mills KR, Reginato M, Debnath J, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proc Natl Acad Sci USA. 2004; 101: 3438-43.
116. Prins J, Ledgerwood E, Ameloot P, et al. Tumour necrosis factor induced autophagy and mitochondrial morphological abnormalities are mediated by TNFR-I and/or TNFR-II and do not invariably lead to cell death. Biochem Soc Trans. 1998; 26: S314.
117. Prins JB, Ledgerwood EC, Ameloot P, et al. Tumor necrosis factor-induced cytotoxicity is not related to rates of mitochondrial morphological abnormalities or autophagy-changes that can be mediated by TNFR-I or TNFR-II. Biosci Rep. 1998; 18: 329-40.
118. Pyo JO, Jang MH, Kwon YK, et al. Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem. 2005; 280: 20722-9.
119. Thorburn J, Moore F, Rao A, et al. Selective inactivation of a Fas-associated death domain protein (FADD)-dependent apoptosis and autophagy pathway in immortal epithelial cells. Mol Biol Cell. 2005; 16: 1189-99.
120. Ryter SW, Choi AM. Autophagy in the lung. Proc Am Thorac Soc. 2010; 7: 13-21.
121. Qian W, Liu J, Jin J, et al. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1. Leuk Res. 2007; 31: 329-39.
122. Basciani S, Vona R, Matarrese P, et al. Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells. FEBS Lett. 2007; 581: 5897-903.
123. Yokoyama T, Miyazawa K, Naito M, et al. Vitamin K2 induces autophagy and apoptosis simultaneously in leukemia cells. Autophagy. 2008; 4: 629-40.
124. Espert L, Denizot M, Grimaldi M, et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest. 2006; 116: 2161-72.
125. Yu L, Alva A, Su H, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science. 2004; 304: 1500-2.
126. Yu L, Lenardo MJ, Baehrecke EH. Autophagy and caspases: a new cell death program. Cell Cycle. 2004; 3: 1124-6.
127. Zalckvar E, Berissi H, Eisenstein M, et al. Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL. Autophagy. 2009; 5: 720-2.
128. Li DD, Wang LL, Deng R, et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene. 2009; 28: 886-98.
129. Takahashi Y, Meyerkord CL, Wang HG. Bif-1/endophilin B1: a candidate for crescent driving force in autophagy. Cell Death Differ. 2009; 16: 947-55.
130. Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005; 122: 927-39.
131. Wei Y, Sinha S, Levine B. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy. 2008; 4: 949-51.
132. Bassik MC, Scorrano L, Oakes SA, et al. Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. EMBO J. 2004; 23: 1207-16.
133. Zhu W, Cowie A, Wasfy GW, et al. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 1996; 15: 4130-41.
134. Gonzalez-Polo RA, Boya P, Pauleau AL, et al. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci. 2005; 118: 3091-102.
135. Criollo A, Vicencio JM, Tasdemir E, et al. The inositol trisphosphate receptor in the control of autophagy. Autophagy. 2007; 3: 350-3.
136. Kim RH, Coates JM, Bowles TL, et al. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009; 69: 700-8.
137. Morselli E, Galluzzi L, Kepp O, et al. Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009; 1793: 1524-32.
138. Wang Y, Zhang Z, Lu Y, et al. Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation. Mol Cancer Res. 2008; 6: 99-109.
139. Tang H, Da L, Mao Y, et al. Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology. 2009; 49: 60-71.
140. Gozuacik D, Bialik S, Raveh T, et al. DAP-kinase is a mediator of endoplasmic reticulum stress-induced caspase activation and autophagic cell death. Cell Death Differ. 2008; 15: 1875-86.
141. Zheng YQ, Liu JX, Li XZ, et al. RNA interference-mediated downregulation of Beclin1 attenuates cerebral ischemic injury in rats. Acta Pharmacol Sin. 2009; 30: 919-27.
142. Luo S, Rubinsztein DC. Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ. 2010; 17: 268-77.
143. Djavaheri-Mergny M, Maiuri MC, Kroemer G. Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene. 2010; 29: 1717-9.
144. Betin VM, Lane JD. Atg4D at the interface between autophagy and apoptosis. Autophagy. 2009; 5: 1057-9.
145. Maiuri MC, Le Toumelin G, Criollo A, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007; 26: 2527-39.
146. Ray R, Chen G. Vande Velde C, et al. BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem. 2000; 275: 1439-48.
147. Ghavami S, Eshraghi M, Kadkhoda K, et al. Role of BNIP3 in TNF-induced cell death-TNF upregulates BNIP3 expression. Biochim Biophys Acta. 2009; 1793: 546-60.
148. Mazure NM, Pouyssegur J. Atypical BH3-domains of BNIP3 and BNIP3L lead to autophagy in hypoxia. Autophagy. 2009; 5: 868-9.
149. Azad MB, Chen Y, Henson ES, et al. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy. 2008; 4: 195-204.
150. Hamacher-Brady A, Brady NR, Logue SE, et al. Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ. 2007; 14: 146-57.
151. Tracy K, Dibling BC, Spike BT, et al. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol. 2007; 27: 6229-42.
152. Mammucari C, Schiaffino S, Sandri M. Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy. 2008; 4: 524-6.
153. Band M, Joel A, Hernandez A, et al. Hypoxia-induced BNIP3 expression and mitophagy: in vivo comparison of the rat and the hypoxia-tolerant mole rat, Spalax ehrenbergi. FASEB J. 2009; 23: 2327-35.
154. Zhang J, Ney PA. NIX induces mitochondrial autophagy in reticulocytes. Autophagy. 2008; 4: 354-6.
155. Galluzzi L, Kroemer G. Shigella targets the mitochondrial checkpoint of programmed necrosis. Cell Host Microbe. 2009; 5: 107-9.
156. Mazure NM, Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival? Curr Opin Cell Biol. 2010; 22: 177-80.
157. Imazu T, Shimizu S, Tagami S, et al. Bcl-2/E1B 19 kDa-interacting protein 3-like protein (Bnip3L) interacts with bcl-2/Bcl-xL and induces apoptosis by altering mitochondrial membrane permeability. Oncogene. 1999; 18: 4523-9.
158. Yasuda M, Han JW, Dionne CA, et al. BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3. Cancer Res. 1999; 59: 533-7.
159. Aouacheria A, Brunet F, Gouy M. Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol Biol Evol. 2005; 22: 2395-416.
160. Datta SR, Katsov A, Hu L, et al. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell. 2000; 6: 41-51.
161. Zhou XM, Liu Y, Payne G, et al. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155. J Biol Chem. 2000; 275: 25046-51.
162. Yasuda M, Theodorakis P, Subramanian T, et al. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem. 1998; 273: 12415-21.
163. Metcalf DG, Law PB, DeGrado WF. Mutagenesis data in the automated prediction of transmembrane helix dimers. Proteins. 2007; 67: 375-84.
164. Ohi N, Tokunaga A, Tsunoda H, et al. A novel adenovirus E1B19K-binding protein B5 inhibits apoptosis induced by Nip3 by forming a heterodimer through the C-terminal hydrophobic region. Cell Death Differ. 1999; 6: 314-25.
165. Sulistijo ES, Jaszewski TM, MacKenzie KR. Sequence-specific dimerization of the transmembrane domain of the "BH3-only" protein BNIP3 in membranes and detergent. J Biol Chem. 2003; 278: 51950-6.
166. Sulistijo ES, MacKenzie KR. Sequence dependence of BNIP3 transmembrane domain dimerization implicates side-chain hydrogen bonding and a tandem GxxxG motif in specific helix-helix interactions. J Mol Biol. 2006; 364: 974-90.
167. Cizeau J, Ray R, Chen G, et al. The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism. Oncogene. 2000; 19: 5453-63.
168. Zhang H, Bosch-Marce M, Shimoda LA, et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem. 2008; 283: 10892-903.
169. Bellot G, Garcia-Medina R, Gounon P, et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol. 2009; 29: 2570-81.
170. Mizutani A, Furukawa T, Adachi Y, et al. A zinc-finger protein, PLAGL2, induces the expression of a proapoptotic protein Nip3, leading to cellular apoptosis. J Biol Chem. 2002; 277: 15851-8.
171. Yang YS, Yang MC, Guo Y, et al. PLAGL2 expression-induced lung epithelium damages at bronchiolar alveolar duct junction in emphysema: bNip3- and SP-C-associated cell death/injury activity. Am J Physiol Lung Cell Mol Physiol. 2009; 297: L455-66.
172. Ghavami S, Chitayat S, Hashemi M, et al. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol. 2009; 625: 73-83.
173. Ghavami S, Eshragi M, Ande SR, et al. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res. 2010; 20: 314-31.
174. Zhou WJ, Deng R, Feng GK, et al. A G-quadruplex ligand SYUIQ-5 induces autophagy by inhibiting the Akt-FOXO3a pathway in nasopharyngeal cancer cells. Chin J Cancer. 2009; 28: 1049-53.
175. Bulcao CF, D'Souza KM, Malhotra R, et al. Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction. J Heart Lung Transplant. 2010; 29: 346-51.
176. Farrall AL, Whitelaw ML. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element. Oncogene. 2009; 28: 3671-80.
177. Tea M, Fogarty R, Brereton HM, et al. Gene expression microarray analysis of early oxygen-induced retinopathy in the rat. J Ocul Biol Dis Infor. 2009; 2: 190-201.
178. Shaw J, Yurkova N, Zhang T, et al. Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival. Proc Natl Acad Sci USA. 2008; 105: 20734-9.
179. van de Sluis B, Groot AJ, Wijmenga C, et al. COMMD1: a novel protein involved in the proteolysis of proteins. Cell Cycle. 2007; 6: 2091-8.
180. Mellor HR, Rouschop KM, Wigfield SM, et al. Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase. Biochem Pharmacol. 2010; 79: 1562-72.
181. Galvez AS, Brunskill EW, Marreez Y, et al. Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J Biol Chem. 2006; 281: 1442-8.
182. Kubli DA, Quinsay MN, Huang C, et al. Bnip3 functions as a mitochondrial sensor of oxidative stress during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2008; 295: H2025-31.
183. Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene. 2008; 27(Suppl. 1): S2-19.
184. Walls KC, Ghosh AP, Ballestas ME, et al. bcl-2/Adenovirus E1B 19-kd interacting protein 3 (BNIP3) regulates hypoxia-induced neural precursor cell death. J Neuropathol Exp Neurol. 2009; 68: 1326-38.
185. Zhang L, Li L, Liu H, et al. BNIP3 mediates cell death by different pathways following localization to endoplasmic reticulum and mitochondrion. FASEB J. 2009; 23: 3405-14.
186. Zhao ST, Chen M, Li SJ, et al. Mitochondrial BNIP3 upregulation precedes endonuclease G translocation in hippocampal neuronal death following oxygen-glucose deprivation. BMC Neurosci. 2009; 10: 113.
187. Tracy K, Macleod KF. Regulation of mitochondrial integrity, autophagy and cell survival by BNIP3. Autophagy. 2007; 3: 616-9.
188. Caires KC, de Avila J, McLean DJ. Vascular endothelial growth factor regulates germ cell survival during establishment of spermatogenesis in the bovine testis. Reproduction. 2009; 138: 667-77.
189. Zhang Z, Yang X, Zhang S, et al. BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia. Stroke. 2007; 38: 1606-13.
190. Zhang L, Li L, Leavesley HW, et al. Cyanide-induced apoptosis of dopaminergic cells is promoted by BNIP3 and Bax modulation of endoplasmic reticulum-mitochondrial Ca2+ levels. J Pharmacol Exp Ther. 2010; 332: 97-105.
191. Kubli DA, Ycaza JE, Gustafsson AB. Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak. Biochem J. 2007; 405: 407-15.
192. Jangamreddy JR, Los M. Mitoptosis, a novel mitochondrial death mechanism leading predominantly to activation of autophagy. Hepat Mon. 2012; 12: (in press, doi: 10.5812/hepatmon.6159).
193. Mijaljica D, Prescott M, Devenish RJ. Mitophagy and mitoptosis in disease processes. Methods Mol Biol. 2010; 648: 93-106.
194. Lyamzaev KG, Nepryakhina OK, Saprunova VB, et al. Novel mechanism of elimination of malfunctioning mitochondria (mitoptosis): formation of mitoptotic bodies and extrusion of mitochondrial material from the cell. Biochim Biophys Acta. 2008; 1777: 817-25.
195. Skulachev VP. Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis. 2006; 11: 473-85.
196. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol. 2001; 2: 589-98.
197. Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology. 1973; 7: 253-66.
198. Holmes T St. George's hospital: case of necrosis of the ulna following diffuse inflammation after injury (and probably simple fracture): removal of a sequestrum involving the whole shaft of the bone for seven inches of its length. Assoc Med J. 1856; 4: 1029.
199. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239-57.
200. Vandenabeele P, Declercq W, Van Herreweghe F, et al. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal. 2010; 3: re4.
201. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980; 68: 251-306.
202. Van Herreweghe F, Festjens N, Declercq W, et al. Tumor necrosis factor-mediated cell death: to break or to burst, that's the question. Cell Mol Life Sci. 2010; 67: 1567-79.
203. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000; 1: 489-95.
204. Denecker G, Vercammen D, Steemans M, et al. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria. Cell Death Differ. 2001; 8: 829-40.
205. Sims JL, Berger SJ, Berger NA. Poly(ADP-ribose) Polymerase inhibitors preserve nicotinamide adenine dinucleotide and adenosine 5'-triphosphate pools in DNA-damaged cells: mechanism of stimulation of unscheduled DNA synthesis. Biochemistry (Mosc). 1983; 22: 5188-94.
206. Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci. 1998; 19: 287-98.
207. Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 1997; 57: 1835-40.
208. Degterev A, Hitomi J, Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008; 4: 313-21.
209. Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005; 1: 112-9.
210. Matthews N. Anti-tumour cytotoxin produced by human monocytes: studies on its mode of action. Br J Cancer. 1983; 48: 405-10.
211. Hitomi J, Christofferson DE, Ng A, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 2008; 135: 1311-23.
212. Zhang DW, Shao J, Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009; 325: 332-6.
213. 2+ stimulation. Arch Biochem Biophys. 2009; 482: 66-76.
214. Chua BT, Guo K, Li P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J Biol Chem. 2000; 275: 5131-5.
215. Lee WK, Abouhamed M, Thevenod F. Caspase-dependent and -independent pathways for cadmium-induced apoptosis in cultured kidney proximal tubule cells. Am J Physiol Renal Physiol. 2006; 291: F823-32.
216. Toyota H, Yanase N, Yoshimoto T, et al. Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett. 2003; 189: 221-30.
217. Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 2007; 117: 326-36.
218. Wu H, Zhu H, Liu DX, et al. Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Cancer Res. 2009; 69: 2453-60.
219. Ben Sahra I, Laurent K, Giuliano S, et al. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res. 2010; 70: 2465-75.
220. Apel A, Herr I, Schwarz H, et al. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008; 68: 1485-94.
221. Leu JI, Pimkina J, Frank A, et al. A small molecule inhibitor of inducible heat shock protein 70. Mol Cell. 2009; 36: 15-27.
222. Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 1999; 59: 59-65.
223. Koneri K, Goi T, Hirono Y, et al. Beclin 1 gene inhibits tumor growth in colon cancer cell lines. Anticancer Res. 2007; 27: 1453-7.
224. Akar U, Ozpolat B, Mehta K, et al. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol Cancer Res. 2007; 5: 241-9.
225. Akar U, Chaves-Reyez A, Barria M, et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy. 2008; 4: 669-79.
226. Turcotte S, Chan DA, Sutphin PD, et al. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell. 2008; 14: 90-102.
227. Burdak-Rothkamm S, Prise KM. New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and nontargeted cells. Eur J Pharmacol. 2009; 625: 151-5.
228. Lowe SW, Schmitt EM, Smith SW, et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993; 362: 847-9.
229. Eriksson D, Stigbrand T. Radiation-induced cell death mechanisms. Tumour Biol. 2010; 31: 363-72.
230. Krepulat F, Lohler J, Heinlein C, et al. Epigenetic mechanisms affect mutant p53 transgene expression in WAP-mutp53 transgenic mice. Oncogene. 2005; 24: 4645-59.
231. McKenna E, Traganos F, Zhao H, et al. Persistent DNA damage caused by low levels of mitomycin C induces irreversible cell senescence. Cell Cycle. 2012; 11: 3132-40.
232. Roberson RS, Kussick SJ, Vallieres E, et al. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res. 2005; 65: 2795-803.
233. te Poele RH, Okorokov AL, Jardine L, et al. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002; 62: 1876-83.
234. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany NY). 2012; 4: 159-65.
235. Demidenko ZN, Zubova SG, Bukreeva EI, et al. Rapamycin decelerates cellular senescence. Cell Cycle. 2009; 8: 1888-95.
236. Korotchkina LG, Leontieva OV, Bukreeva EI, et al. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY). 2010; 2: 344-52.
237. Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012; 441: 1-21.
238. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002; 2: 647-56.
239. Schmitt E, Paquet C, Beauchemin M, et al. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation. Oncogene. 2004; 23: 3915-31.
240. Hossini AM, Geilen CC, Fecker LF, et al. A novel Bcl-x splice product, Bcl-xAK, triggers apoptosis in human melanoma cells without BH3 domain. Oncogene. 2006; 25: 2160-9.
241. Lin ML, Park JH, Nishidate T, et al. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family. Breast Cancer Res. 2007; 9: R17.
242. Pujianto DA, Damdimopoulos AE, Sipila P, et al. Bfk, a novel member of the bcl2 gene family, is highly expressed in principal cells of the mouse epididymis and demonstrates a predominant nuclear localization. Endocrinology. 2007; 148: 3196-204.
243. Domina AM, Smith JH, Craig RW. Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition. J Biol Chem. 2000; 275: 21688-94.
244. Yoon SJ, Kim EY, Kim YS, et al. Role of Bcl2-like 10 (Bcl2l10) in Regulating Mouse Oocyte Maturation. Biol Reprod. 2009; 81: 497-506.